Back to mobile site
Get it on Google Play

Incannex receives FDA fast track designation for sleep apnea drug

December 3, 2025 8:00 AM EST Send to a Friend
Incannex Healthcare Inc. (NASDAQ: IXHL) announced that the U.S. Food and Drug Administration has granted Fast Track designation for IHL-42X ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login